Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 3
1997 1
1999 10
2000 9
2001 4
2002 5
2003 7
2004 9
2005 4
2006 15
2007 18
2008 11
2009 14
2010 7
2011 7
2012 8
2013 7
2014 4
2015 7
2016 3
2017 2
2018 3
2019 1
2020 2
2021 4
2022 4
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Neurological complications of dengue virus infection.
Carod-Artal FJ, Wichmann O, Farrar J, Gascón J. Carod-Artal FJ, et al. Lancet Neurol. 2013 Sep;12(9):906-919. doi: 10.1016/S1474-4422(13)70150-9. Lancet Neurol. 2013. PMID: 23948177 Review.
Neuroschistosomiasis.
Carod-Artal FJ. Carod-Artal FJ. Expert Rev Anti Infect Ther. 2010 Nov;8(11):1307-18. doi: 10.1586/eri.10.111. Expert Rev Anti Infect Ther. 2010. PMID: 21073294 Review.
American trypanosomiasis.
Carod-Artal FJ. Carod-Artal FJ. Handb Clin Neurol. 2013;114:103-23. doi: 10.1016/B978-0-444-53490-3.00007-8. Handb Clin Neurol. 2013. PMID: 23829903 Review.
Post-Ebolavirus disease syndrome: what do we know?
Carod-Artal FJ. Carod-Artal FJ. Expert Rev Anti Infect Ther. 2015;13(10):1185-7. doi: 10.1586/14787210.2015.1079128. Epub 2015 Aug 13. Expert Rev Anti Infect Ther. 2015. PMID: 26293407
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
160 results